Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Ovarian Cancer × liposomal doxorubicin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 104 Breast Neoplasms 76 Fallopian Tube Neoplasms 45 Multiple Myeloma 32 Carcinoma, Ovarian Epithelial 26 Neoplasms 23 Lymphoma 16 Sarcoma 13 Triple Negative Breast Neoplasms 12 Recurrence 12 Neoplasm Metastasis 12 Lymphoma, Large B-Cell, Diffuse 10 Lymphoma, Non-Hodgkin 8 Hodgkin Disease 8 Prostatic Neoplasms 6 Neoplasms, Plasma Cell 6 Pancreatic Neoplasms 5 Burkitt Lymphoma 5 Solid Tumors 4 Sarcoma, Kaposi 4 Sarcoma, Ewing 4 Lymphoma, T-Cell, Peripheral 4 Lymphoma, Mantle-Cell 4 Leiomyosarcoma 4 Endometrial Neoplasms 4 Carcinoma 4 Breast Neoplasms, Male 4 Uterine Cervical Neoplasms 3 Rhabdomyosarcoma 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3

Interventions

Saline Solution 3 Carboplatin 2 Bevacizumab 2 talazoparib 1 stenoparib 1 senaparib 1 sargramostim 1 olaparib 1 niraparib 1 liposomal doxorubicin 1 Tranexamic Acid 1 Ropivacaine 1 Paclitaxel 1 Observation 1 Neoadjuvant Therapy 1 Hyperthermic Intraperitoneal Chemotherapy 1 Antineoplastic Agents 1 1-dodecylpyridoxal 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03161132 2023-01-27

ROLANDO

Grupo Español de Investigación en Cáncer de Ovario

Phase 2 Completed

Advanced Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡